Tissue transglutaminase (tTG) is a unique member of the transglutaminase family as it is both a transamidating enzyme and a GTPase. In the cell tTG is mostly cytosolic, however it is also found in the nucleus and associated with the plasma membrane. tTG can be pro-apoptotic, however anti-apoptotic activities of the enzyme have also been reported. To determine how the intracellular localization and transamidating activity of tTG modulates its effects on apoptosis, HEK 293 cells were transiently transfected with tTG or C277S-tTG (which lacks transamidating activity) constructs that were targeted to different intracellular compartments. Apoptosis was induced by thapsigargin treatment, which results in increased intracellular calcium concentrations. Cytosolic tTG was proapoptotic, while nuclear localization of C277S-tTG attenuated apoptosis.
INTRODUCTION
Tissue transglutaminase (tTG 1 ) is a unique member of the transglutaminase family of proteins (for a review see (1, 2) ). Transglutaminases catalyze a calcium dependent transamidation reaction that results in protein crosslinking, polyamination or deamination (1, 3, 4) . Tissue TG is a multifunctional enzyme as in addition to transamidating activity it also has GTPase activity and may act as a signal transducing G protein (5) (6) (7) . Tissue TG has been implicated in numerous cellular processes such as wound healing (8) , differentiation (9-11), apoptosis (12,13), and cell survival (14) (15) (16) . Further, although tTG is found mostly in the cytosol, it is also present in the nucleus (17, 18) and associated with the plasma membrane (19) . Since intracellular localization affects protein function by determining what interactions are likely to occur, it is possible that by having access to different substrates in different intracellular pools the multiplicity of tTG's effects in different cellular pathways may be due to both its localization and which enzymatic activity of tTG is favored (transamidating or GTP binding/hydrolyzing).
increased the transamidating activity of the enzyme, tTG was pro-apoptotic.
However, tTG ameliorated apoptosis when the stressor did not result in an increase in the transamidating activity (15) . These findings suggest that the effects of tTG on apoptosis are complex and likely due in part to its multifunctional character.
The focus of the present study was on determining how both tTG localization and transamidating activity modulated apoptosis. To accomplish this goal, HEK 293 cells were transiently transfected with wild-type tTG (tTG) or tTG without transamidating activity (C277S-tTG) that were tagged with a nuclear localization sequence (NLS), or a signal sequence that directed proteins to the plasma membrane (Myr/Pal) or with tTG or C277S-tTG that lacked any added cellular localization sequences and therefore are predominantly cytosolic (17) . Apoptosis was subsequently induced by treatment with thapsigargin, an inhibitor of the Ca ++ -ATPase of endoplasmic reticulum that has been shown to induce apoptosis in different cell models (23) (24) (25) . After induction of cell death differential effects of the tTG constructs on the apoptotic process were observed: (i) wild-type tTG without any added cellular localization signals facilitated apoptosis, (ii) transamidating inactive tTG localized in the nucleus (NLS-C277S) ameliorated apoptosis, and (iii) localizing tTG to the membrane had no effect on apoptosis.
These findings show that the effects of tTG on the apoptotic process are dependent on the localization of the enzyme in the cell, and its multiple functions.
Further, we demonstrated that tTG interacts with retinoblastoma (Rb) protein, a primarily nuclear protein that plays a key role in the regulation of apoptosis (26). However, after apoptosis was induced and the transamidating activity of tTG activated, the interaction between nuclear localized wild-type tTG (NLS-tTG) and Rb was decreased, while the interaction of NLS-C277S with Rb was increased.
Overall, our data demonstrate for the first time that tTG differentially modulates apoptosis in an intracellular localization and transamidating activity dependent manner. We also provide evidence that tTG binds to Rb both in the cytosol and nucleus, however induction of apoptosis impacts only nuclear tTG-Rb interactions. Given importance of Rb in the regulation of apoptosis (26), this interaction may be crucial for elucidating the mechanism by which tTG can protect cells against apoptosis.
EXPERIMENTAL PROCEDURES

Constructs
Six different tTG constructs were used in this study. The pcDNA3.1-tTG and pcDNA3.1-C277S-tTG constructs containing cDNA for human tTG or transglutaminase inactive tTG mutant respectively have been described previously (27). To make the NLS tagged constructs, the cDNA for human tTG or C277S-tTG was amplified from the pcDNA3.1 vectors by Pfu DNA polymerasecatalyzed PCR using a pair of DNA primers, the forward (5'-CCC GAC CAT GGC 7 constructs, pCMV-tTG-NLS, pCMV-C277S-tTG-NLS contained cDNA for tTG or C277S-tTG fused in frame C-terminally with the 3X nuclear localization signal (NLS) from SV40 large T antigen (28).
To generate DNA constructs that localize tTG and C277S-tTG to the plasma membrane a two-step procedure was used. In the first step cDNA for tTG or C277StTG was amplified by PCR using the forward primer (5'-CGC GAA TTC TGA TGG CCG AGG AGC TGG TC-3') containing an EcoRI site and the reverse primer (5'-CCG CGG TAC CGT GGC GGG GCC AAT GAT GAC-3') containing a KpnI site, digested with EcoRI and KpnI and subsequently ligated into the EcoRI/KpnI cloning sites of pcDNA3.1(-)/myc-His B vector (Invitrogen). The above step resulted in generation of pcDNA-tTG-myc-His and pcDNA-C277S-myc-His constructs in which cDNA for tTG or C277S-tTG was fused in frame with a C-terminus myc epitope and polyhistidine tag. In the second step a doublestrand 67-base synthetic oligonucleotide (top strand: 5'-CCC GCT AGC ATG GGC TGT GTG CAA TGT AAG GAT AAA GAA GCA ACA AAA CTG ACG GAG GGA ATT CGC C-3') encoding the 17-amino acid N-terminus of Fyn that is both myristylated and palmitoylated and thus constitutively targets the protein to the plasma membrane (29) and containing NheI and EcoRI restriction sites was used. It was inserted into the NheI/EcoRI cloning sites of pcDNA-tTG-mycHis and pcDNA-C277S-myc-His constructs resulting in a Myr/Pal tag at the Nterminus of tTG or C277S-tTG. All DNA constructs were verified by automated sequencing. 
Cell culture
Human embryonic kidney (HEK) 293 cells were cultured in Ham's F-12/Dulbecco's modified Eagle medium (DMEM; Irvine Scientific) supplemented with 5% fetal bovine serum (FBS; HyClone), 2 mM L-glutamine (Gibco), 100 µg/ml streptomycin (Gibco) and 100 U/ml penicillin (Gibco). Cells were grown in humidified atmosphere containing 5% CO 2 at 37 o C. Transient transfections were carried out using FUGENE 6 transfection reagent (Roche) according to the manufacturer's instructions.
Cell treatment paradigm
Twenty-four hours after transfection, cells (50-60% confluency) were transferred to serum-free media and 12 hours later the cells were treated with 5-8 µM 
Caspase-3 assay
After treatment, cells were harvested in media, rinsed once with ice-cold PBS and resuspended in lysis buffer. Caspase-3 activity was measured as described previously (15) .
Nuclear fractionation
Cells were washed twice, harvested in ice-cold PBS and the cell pellets were 
Plasma membrane fractionation
Plasma membrane fractions were prepared as described previously (30). Briefly, cell surfaces were labeled with sulfosuccinimidyl 2-(biotinamide) ethyl-1,3-dithiopropionate (Pierce), cells were then incubated with previously prepared streptavidin-coupled microspheres (Sigma) and harvested. A magnetic bead attractor was used to separate bound fractions (plasma membrane) from unbound fractions (cytosol, organelles). Plasma membranes were then separated from the microspheres using buffer with 0.1M β-mercaptoethanol (Sigma). Cytosolic fractions were separated from organelles by high-speed centrifugation of the unbound fractions. Plasma membrane fractions and cytosol fractions were precipitated separately using 2% Na deoxycholate and 24% trichloroacetic acid, and pellets were resuspended in SDS buffer.
In situ transglutaminase activity assay
In situ transglutaminase activity was measured as described previously (31).
Briefly, cells were labeled with 2 mM 5-(biotinamido)pentylamine (BAP) (Pierce) for 2 h and then treated with thapsigargin for 4 h. Cells were collected, washed and pelleted. Pellets were resuspended in homogenization buffer (50 mM Tris [pH 7.5], 150 mM NaCl, 1 mM EDTA), sonicated on ice, and protein concentrations were determined using the BCA assay. The incorporation of BAP into proteins was quantified as described previously (31). 
Luciferase assay
Statistics
All data were analyzed using ANOVA. The values were considered significantly different when p<0.05. Results were expressed as mean ± SEM.
RESULTS
Expression of tTG constructs in HEK 293 cells
To determine the relative expression levels of the different tTG constructs, HEK 
Subcellular localization of tTG in transfected cells
The subcellular localization of the differentially tagged tTG constructs was verified by performing fractionation experiments of transiently transfected HEK 293 cells. To determine the subcellular localization of the NLS tagged tTG constructs (NLS-tTG, NLS-C277S), cells were separated into cytosolic and nuclear fractions. As expected, small amounts of tTG and C277S were found in the nucleus ( Fig. 2A) as it has been previously reported for endogenous tTG (17, 18) , however NLS-tTG and NLS-C277S were found predominantly in the nucleus ( Fig. 2A) . The lighter lower band in the cytosolic fractions from the cells transfected with NLS-tTG or NLS-C277S corresponds to endogenous tTG ( Fig.   2A ). To confirm the purity of the cytosolic and nuclear fractions, the fractions were immunoblotted for histone, a nuclear protein or β-tubulin, a cytosolic protein. Histone was found only in the nuclear fractions, while β-tubulin was only in the cytosolic fractions (Fig 2A) . To determine the subcellular localization of the expected, the insulin receptor β subunit was present  only in the membrane fractions and β-tubulin in the cytosolic fractions (Fig. 2B) .
In situ transglutaminase activity in transfected cells
To determine how the transamidating activity of the different tTG constructs was affected in the thapsigargin treated cells an in situ transglutaminase assay was used (31). Thapsigargin, an inhibitor of the Ca ++ -ATPase of endoplasmic reticulum, has been shown to produce an increase in intracellular calcium levels in numerous cell types (32-34). Additionally, prolonged thapsigargin treatment has been shown to induce apoptotic cell death in various cell models (23) (24) (25) .
Our results clearly demonstrate that thapsigargin treatment significantly increased in situ transglutaminase activity in the cells transfected with tTG or Myr/Pal-tTG, but not in cells transfected with the C277S mutants when compared to cells transfected with vector only (Fig. 3A) . When whole cell lysates were used in the assay, no significant increase in transglutaminase activity was observed in the NLS-tTG transfected cells compared to vector transfected cells after thapsigargin treatment (Fig. 3A) . However, when transglutaminase activity was measured in crude nuclear fractions, a significant increase was observed in the NLS-tTG transfected cells in response to thapsigargin treatment, with no significant increase occurring in the NLS-C277S transfected cells (Fig. 3B) .
Intracellular localization and transamidating activity of tTG differentially impacts thapsigargin-induced apoptosis
There is increasing evidence for the involvement of tTG in the process of apoptosis. Several studies have suggested that tTG is pro-apoptotic (21, 22) while other studies have shown that tTG attenuates apoptosis (14-16).
Interestingly, it has been shown that the effects of tTG on apoptosis may depend on the type of apoptotic inducer and how the stress impacts the activity of tTG (15) . To investigate how the localization and activity of tTG affects apoptosis, HEK 293 cells were transiently transfected with the different tTG constructs and subsequently treated with thapsigargin (or vehicle only) prior to measuring caspase activity as an indicator of apoptosis. Thapsigargin treatment resulted in a significant increase in caspase-3 activation in all transfected cells. However, caspase-3 activity was significantly greater in cells transfected with tTG, which is predominantly cytosolic, compared to cells transfected with vector only (Fig. 4B) , while expression of NLS-tTG or Myr/Pal-tTG did not significantly affect caspase-3 activity compared to the vector (pc) control groups (Fig 4A) . Expression of C277S without any subcellular localization signal or Myr/Pal-C277S also did not have any effect on caspase-3 activation in response to thapsigargin treatment relative to the vector (pc) transfected cells (Fig. 4B) . However, thapsigargin-induced caspase-3 activation was significantly attenuated in the cells transiently expressing transamidation inactive tTG mutant, localized in the nuclear compartment (NLS-C277S) (Fig. 4B) . These data indicate that tTG localized to the cytosol that is active as a transamidating enzyme is pro-apoptotic, while (Fig. 5) . More interestingly, in the nucleus this interaction is dynamic and dependent upon the transamidating activity of tTG, as after induction of apoptosis nuclear localized wild-type tTG (NLS-tTG) is released from the complex with Rb, while the binding of the nuclear localized transamidating inactive mutant (NLS-C277S) tTG to Rb increases (Fig. 5B) . In contrast, the interaction of tTG with Rb protein in the cytosol is unaffected by thapsigargin treatment. To determine if this affect was specific for Rb, the interaction between nuclear localized tTGs (NLS-tTG and NLS-C277S) and histone H2B, another nuclear protein reported to interact with tTG and be its substrate (41, 42) , was investigated. Histone H2B complexed with both NLS-tTG and NLS-C277S but there was no changes in this interaction after apoptosis was induced (data not shown). This suggests that the dynamic character of tTG's interaction with Rb in the nucleus after induction of apoptosis is specific and that this interaction may be significant for tTG effects on apoptosis when localized in the nucleus. were transfected with an E2F reporter vector and Renilla vector as an internal control, together with the expression vectors (pcDNA, NLS-tTG or NLS-C277S), and subsequently incubated in the absence or presence of thapsigargin prior to the measurement of luciferase activity. These data demonstrate that treatment with thapsigargin did not result in significant changes in E2F activity, although E2F transcriptional activity was slightly, although statistically decreased (~30 %) in the NLS-tTG expressing cells compared to vector transfected (pc) cells (Fig.   6B ). Rb also interacts with and regulates histone deacetylase (HDAC) activity (45) , and this may have important effects on the apoptotic process through transcriptional repression (46) . Therefore we also investigated the affects of NLStTG and NLS-C277S on Rb-HDAC interactions using the same protocol as for Rb-E2F interactions. Neither NLS-tTG nor NLS-C277S had any effect on Rb-HDAC interactions in the absence or presence of thapsigargin (data not shown).
It has been proposed that the levels of Rb are important in regulating its affects on apoptosis and several studies have shown that cleavage of Rb occurs early in apoptosis (47-49). It has also been shown that cells expressing caspaseresistant Rb are protected from apoptosis (50) . Therefore, we investigated if NLS-tTG or NLS-C277S affected Rb stability during thapsigargin-induced apoptosis. HEK293 cells were transfected with either NLS-tTG or NLS-C277S followed by treatment with thapsigargin. Although Rb was degraded 24 hr after treatment with thapsigargin, the results of these studies revealed the extent of Rb degradation was not different between NLS-tTG (0.58±0.15,n=3 experiments) and NLS-C277S (0.69±0.21,n=3 experiments) transfected cells, indicating that NLS-tTG is not attenuating apoptosis by increasing the stability of Rb.
DISCUSSION
Tissue transglutaminase has been shown to be both pro-and anti-apoptotic (15, 16, 21) . Indeed tTG is increased both in conditions such as neurodegenerative disorders where there is increased cell death in specific brain regions (51-53), and in some tumors which are characterized by a lack of apoptosis (54, 55) . Therefore it is of critical importance to investigate the role of tTG in the process of apoptosis. The present study demonstrates for the first time that the effects of tTG on the apoptotic cell death process are strongly dependent upon its localization in the cell. Wild type tTG localized predominantly in the cytosolic compartment facilitated apoptosis, while both membrane and nuclear localized wild type tTGs did not significantly affect the apoptotic cell death process. Further, our study emphasizes the importance of the transamidating activity of tTG in the cytosol for the facilitation of the apoptotic cell death process since tTG's pro-apoptotic effect in the cytosolic compartment was completely abolished in cells expressing the transglutaminase inactive mutant tTG-C277S.
In contrast to the pro-apoptotic function of wild type tTG, the transglutaminase inactive mutant C277S-tTG significantly protected cells against apoptosis when it was shuttled to the nuclear compartment. Therefore this study provides significant evidence that the nuclear space is the place where tTG exerts its antiapoptotic effects. Overall, the findings presented in this paper begin to delineate the seemingly contradictory roles of tTG as both a facilitator and suppressor of apoptosis.
In the cell, tTG is present mostly in the cytosol, although it is also in the nucleus and associated with the plasma membrane (17, 19) . In this study we demonstrate that when tTG is localized mostly in the cytosol, it facilitates apoptosis. Further, and in agreement with a previous study (15), we found that the transamidating activity of tTG is necessary for its pro-apoptotic activity in the cytosol. Both membrane and nuclear localized wild-type tTG did not affect apoptosis, even though thapsigargin treatment resulted in a significant increase in the transamidating activity of these constructs. These data suggest that tTG must modify specific substrates in the cytosol to be pro-apoptotic, and sequestering tTG at the membrane or in the nucleus prevents these interactions.
It has been shown that tTG migrates to the nucleus in response to specific stressors (17) , and importin-3 has been identified as a possible transporter responsible for the translocation of tTG into the nucleus (56) . Here, we demonstrate that tTG localized in the nucleus attenuates apoptosis when it is not active as a transamidating enzyme. Therefore, translocation of tTG into the nucleus may be protective for the cell. So why is nuclear tTG without transamidating activity anti-apoptotic? Previous studies have suggested that tTG may regulate Rb activity (14, 35) . Rb is a nuclear phosphoprotein that is important regulator of proliferation, differentiation and apoptosis (26, 57, 58) . Therefore, we investigated the interaction of tTG with Rb in our apoptosis model. We found that tTG interacts with Rb both in cytosol and nucleus. Further, the C277 site that is critical for transamidating activity is not necessary for this interaction.
Interestingly, after apoptosis was induced, nuclear localized tTG with transamidating activity (NLS-tTG) was released from Rb, while the interaction between the transamidating inactive mutant (NLS-C277S) and Rb in the nucleus increased. The interaction between tTG and Rb in the cytosol was not altered after apoptosis was induced. This is the first demonstration that tTG interacts with Rb in an intracellular localization and transamidating activity dependent manner in response to an apoptotic stimulus. These findings indicate that tTG is protective against apoptosis only when it is in the nucleus and is not active as a transamidating enzyme and that its interaction with Rb may play a central role in this process. These studies differ somewhat from a previous report (14) in which it was postulated that Rb was modified by tTG and that this resulted in decreased proteolysis of Rb, which was anti-apoptotic. However in this previous study (14) there was no direct demonstration that Rb was modified by tTG and therefore the anti-apoptotic effects of tTG maybe due to the interaction of tTG and Rb, rather than a modification of Rb. It is important to mention that we also investigated the interaction of tTG with another nuclear protein, histone H2B, which has been reported to be a tTG substrate and to interact with tTG (41, 42) and no differences in this interaction were observed before or after induction of apoptosis with any of the tTG constructs. Therefore the dynamic character of tTG's interaction with Rb is specific, substantiating the hypothesis that this interaction may be significant for the effect of tTG on apoptosis when localized in the nucleus.
Rb likely plays an important role in apoptosis as Rb-deficient mice die very early, and show increased susceptibility to apoptosis in several developing tissues (59,60). The question is if the binding of tTG to Rb affects Rb's function or its stability. Rb is a phosphoprotein and when Rb is hypophosphorylated it binds to E2F and keeps E2F transcriptionally inactive, and therefore is anti-apoptotic (44) . Also, when bound to E2F, Rb recruits HDAC to repress transcription (46) .
Although NLS-C277S interacted with Rb and was anti-apoptotic, this interaction had no effect on E2F activity or Rb's interaction with HDAC. However, it has been suggested that its not the phosphorylation state of Rb that is important for regulation of apoptosis, but the overall level of Rb in the cell (26). Through interaction with E2F Rb can suppress transcription of different apoptotic genes.
However, apoptosis in Rb null embryos is not always suppressed by E2F gene disruption (61). These findings indicate that Rb can be anti-apoptotic through mechanisms other than suppression of E2F activity. Therefore we examined the overall levels of Rb before and after apoptosis was induced. Although, Rb was degraded in response to treatment with thapsigargin, there were no differences in the extent of proteolysis between NLS-C277S and NLS-tTG expressing cells.
Therefore, further studies are required to elucidate the mechanisms by which NLS-C277S attenuates the apoptotic process.
How is it decided if tTG will be pro-apoptotic, anti-apoptotic, or have no effect on apoptosis? It has been shown that tTG modulates apoptosis in a stimulus dependent manner (15) . It is well known that for tTG to exhibit transamidating activity, an increase in intracellular calcium levels is necessary (31). Since different apoptotic stimuli activate different signaling pathways and differentially effect intracellular calcium levels, it can be postulated that increases in the levels of calcium in certain cellular compartments in response to a specific stressor is one of the factors that determines the effects of tTG on the apoptotic process.
Indeed, tTG potentiated apoptosis in response to osmotic stress, a stimulus that significantly increases in situ TG activity (15), most likely due to an increase in intracellular calcium (62,63). In contrast tTG protected against heat shock induced apoptosis, a stressor that did not increase tTG activity (15) . Another deciding factor would be how a certain stressor affects tTG transport to the nucleus. Therefore it can be hypothesized that the combined effects of the concentration of calcium within a given intracellular compartment, and the location of tTG within the cell likely determine how tTG modulates apoptosis.
In conclusion, we believe that the present findings contribute to our understanding of the complex role of tTG in apoptosis. These findings clearly demonstrate that the transamidating activity of tTG is essential for its proapoptotic effects, while the anti-apoptotic effects of tTG only occur in the absence of transamidating activity. Further, we demonstrate for the first time that nuclear localization of tTG is protective against apoptosis when it is not active as a transamidating enzyme. The anti-apoptotic effects of tTG in the nucleus may due to the increased interaction of tTG with Rb. Overall, it is clear that tTG plays an important, but complex regulatory role in the process of apoptosis. 
